KYAN Technologies | Company Profile - Revenue, Headcount, Tech Stack, Contacts
Contact Information
Industry & Market
Company Metrics
Funding Information
Headcount Distribution
By Department
Department Breakdown
Technology Stack
Email & Communication
Keywords & Focus Areas
KYAN Technologies
Overview
Based in Singapore, this biotechnology company specializes in functional precision medicine for oncology. It leverages advanced technology and expertise to address gaps in cancer treatment, aiming to enhance care and outcomes. The organization is growing its presence in the U.S. to expand clinical deployment and strengthen strategic collaborations in oncology research and healthcare.
Its flagship product, Optim.AI™, is a validated functional precision medicine test and combinatorial drug sensitivity platform. Optim.AI™ uses ex vivo testing and advanced analytics on patient-derived tumor samples to identify effective drug-dose combinations, providing actionable insights to support oncologists in making personalized treatment decisions. Since 2023, the platform has been available to clinicians and patients internationally. The company has partnered with leading institutions such as the National University of Singapore and Mayo Clinic Laboratories to advance cancer diagnostics and therapy.
Basic Information
| Industry | research |
|---|---|
| Founded | 2016 |
| Revenue | 2.1M |
| Headquarters | 1 Research Link, 05-30, -05-45, Singapore, 117604, Singapore |
Contact Details
- Phone: +65 9730 2672
- Website: kyantechnologies.com
- LinkedIn: linkedin.com/company/kyan-therapeutics
Key Focus Areas & Initiatives
- Drug development
- Dosage optimization
- Licensing
- Distribution
- Oncology
- Infectious diseases
- Clinical development
- Biotechnology
- Pharmaceuticals
- Digital healthcare
- Personalized medicine
- Biotechnology research
- Hospital & health care
- Medical
Technologies Used
- AI
- Gmail
- Google Apps
- Google Cloud Hosting
- Microsoft Office 365
Community
